近日，蓝丰生化（Lanfeng Biochemical）发布公告称，公司持股5%以上股东海南闻勤企业管理合伙企业（有限合伙）（以下简称“海南闻勤”）计划在未来六个月内，通过集中竞价或大宗交易方式减持公司股份，减持比例不超过公司总股本的3%。本次减持系海南闻勤基于自身资金需求及投资安排所作出的决策，不涉及公司控制权变更，亦不会对公司治理结构及持续经营产生重大影响。蓝丰生化是一家专注于农药、精细化工产品研发、生产和销售的上市公司，近年来在环保政策趋严和行业整合背景下，公司积极推进转型升级。此次股东减持虽属正常市场行为，但仍可能对短期股价造成一定波动。投资者应关注减持的具体时间、方式及后续资金用途等细节，理性判断公司基本面与长期价值。值得注意的是，海南闻勤此前已多次参与蓝丰生化的股权结构调整，其持股变动一直受到市场关注。公司表示将督促相关股东严格遵守信息披露及减持相关规定，确保市场公平透明。
Recently, Lanfeng Biochemical announced that Hainan Wenqin Enterprise Management Partnership (Limited Partnership) (“Hainan Wenqin”), a shareholder holding more than 5% of the company’s shares, plans to reduce its stake by up to 3% of the company’s total share capital within the next six months through centralized bidding or block trading. This proposed divestment stems from Hainan Wenqin’s own liquidity needs and investment planning, and will not result in any change of control or significantly impact the company’s governance structure or ongoing operations.Lanfeng Biochemical is a publicly listed company specializing in the research, development, production, and sales of pesticides and fine chemical products. In recent years, amid tightening environmental regulations and industry consolidation, the company has actively pursued transformation and upgrading. While this share reduction represents a normal market activity, it may cause short-term stock price volatility. Investors are advised to closely monitor the timing, method, and intended use of proceeds from the divestment to make informed judgments about the company’s fundamentals and long-term value.Notably, Hainan Wenqin has previously participated multiple times in equity restructuring at Lanfeng Biochemical, and its shareholding changes have consistently drawn market attention. The company stated it will ensure that relevant shareholders strictly comply with disclosure and share-reduction regulations to maintain market fairness and transparency.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/18277.html